phosphatidylcholines has been researched along with dihydropyridines in 7 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 5,022 | 529 | 969 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Fekete, Z; Liu, J; Slomiany, A; Slomiany, BL; Yao, P | 1 |
| Mason, RP; Moisey, DM; Shajenko, L | 1 |
| Mason, RP | 1 |
| Krishnakumari, V; Nagaraj, R | 1 |
| Hof, M; Javanainen, M; Jungwirth, P; Jurkiewicz, P; Kulig, W; Manna, M; Olżyńska, A; Rog, T; Tynkkynen, J; Vattulainen, I | 1 |
| Gabrielska, J; Huszcza, E; Strugała, P; Tronina, T | 1 |
| Abdel Halim, SA; Badr-Eldin, SM; Naguib, MJ; Salah, S | 1 |
1 review(s) available for phosphatidylcholines and dihydropyridines
| Article | Year |
|---|---|
Membrane interaction of calcium channel antagonists modulated by cholesterol. Implications for drug activity.
Topics: Animals; Biological Availability; Calcium Channel Blockers; Calcium Channels; Cardiovascular System; Cell Membrane; Cholesterol; Dihydropyridines; Humans; Lipid Bilayers; Models, Molecular; Phosphatidylcholines; Receptors, Drug | 1993 |
6 other study(ies) available for phosphatidylcholines and dihydropyridines
| Article | Year |
|---|---|
Modulation of dihydropyridine-sensitive gastric mucosal calcium channels by GM1-ganglioside.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Radioisotopes; Cell Membrane; Dihydropyridines; G(M1) Ganglioside; Gastric Mucosa; Isradipine; Lanthanum; Liposomes; Male; Osmolar Concentration; Phosphatidylcholines; Rats; Rats, Inbred Strains | 1992 |
Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cell Membrane; Cholesterol; Dihydropyridines; Diltiazem; Electrons; Isradipine; Lipid Bilayers; Myocardium; Nifedipine; Nimodipine; Nitrendipine; Phosphatidylcholines; Rabbits; Verapamil | 1992 |
Binding of peptides corresponding to the carboxy-terminal region of human-β-defensins-1-3 with model membranes investigated by isothermal titration calorimetry.
Topics: Adsorption; Bacteria; beta-Defensins; Calorimetry, Indirect; Dihydropyridines; Diphenylhexatriene; Fluorescence Polarization; Humans; Membranes, Artificial; Phosphatidylcholines; Phosphatidylethanolamines | 2012 |
Experimental determination and computational interpretation of biophysical properties of lipid bilayers enriched by cholesteryl hemisuccinate.
Topics: 2-Naphthylamine; Cholesterol; Cholesterol Esters; Dihydropyridines; Laurates; Lipid Bilayers; Liposomes; Molecular Dynamics Simulation; Phosphatidylcholines; Protons; Water | 2015 |
Bioactivity In Vitro of Quercetin Glycoside Obtained in Beauveria bassiana Culture and Its Interaction with Liposome Membranes.
Topics: Antioxidants; Beauveria; Culture Media; Cyclooxygenase 1; Cyclooxygenase 2; Dihydropyridines; Diphenylhexatriene; Fluorescent Dyes; Glycosides; Glycosylation; Humans; Liposomes; Phosphatidylcholines; Quercetin; Serum Albumin, Human; Solutions; Stereoisomerism | 2017 |
Investigating the potential of utilizing glycerosomes as a novel vesicular platform for enhancing intranasal delivery of lacidipine.
Topics: Administration, Intranasal; Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cholesterol; Dihydropyridines; Disease Models, Animal; Drug Compounding; Drug Liberation; Glycerol; Hypertension; Liposomes; Male; Methylprednisolone Acetate; Nasal Absorption; Nasal Mucosa; Permeability; Phosphatidylcholines; Rats, Wistar; Solubility | 2020 |